DOCS NYSE Week ended 31 Jul 2026

Weekly Investor Report

Doximity Inc · Healthcare · Health Information Services

Open interactive chart View report data
Latest close 20.91 USD
2.4% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -17.0% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned 2.4%, after a -4.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 64/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 4d.

Setup score 26 out of 100
Latest Close 20.91 USD 31 Jul 2026
1W Return 2.4% latest completed week
4W Return -4.3% short-term follow-through
12W Return -19.5% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.4% Latest completed week; four-week move -4.3%. Indicator stack 10/65 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 64/100 conviction; expected move 20.2%. News sentiment 49/100 55 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -17.0% below the Trend Line and sits at 6.3% of its 52-week range. The latest completed week returned 2.4%, after a -4.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.1512-week average 0.08

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.15Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.3% over four weeks, -19.5% over 12 weeks, and -63.5% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W2.4%
4W-4.3%
12W-19.5%
26W-44.2%
52W-63.5%
Active trend streak0 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.73Latest activity-pressure read.
Pressure change21.5%Four-week change in activity pressure.
Leadership-52.80Latest relative-leadership reading.
RS change3.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 97% Model confidence 93%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength33/100Blend of value, momentum, and quality. Underlying universe rank 68; rank 1 is best.
Value33/100Relative valuation strength. Underlying universe rank 68; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum3/100Medium-term price momentum. Underlying universe rank 98; rank 1 is best.
Growth79/100Revenue and earnings growth. Underlying universe rank 22; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework76/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
18.7x
Price divided by trailing earnings.
Price / sales
5.7x
Market value relative to trailing revenue.
EV / EBITDA
13.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
9.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
89.1%
Gross profit retained from each unit of revenue.
Operating margin
38.8%
Operating profit retained from revenue.
Free-cash-flow margin
52.0%
Free cash flow generated from revenue.
Return on invested capital
26.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
13.1%
Latest one-year revenue growth.
EPS growth
-12.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
19.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
11.4%
Net share repurchases relative to market value.
Shareholder yield
11.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.8x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

DOCS shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 7.20, expected move of 20.2%, and Sharemaestro trend signal inactive.

Conviction64/100
Expected move20.2%
Put/call volume7.20
Pressure-73
Speculation19
Volatility96
Trend agreement73
Open options detail
Insider activity10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 55 relevant articles.

7 positive · 39 neutral · 9 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move20.2%Nearest-chain priced movement where available.
52-week drawdown-72.7%Distance below the 52-week high.
13-week volatility8.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher12 of 2614 weeks finished lower.
Best week+17.4%Week of 17 Apr.
Worst week-27.0%Week of 15 May.
Latest week+2.4%Week of 31 Jul.

Shape of recent returns

Strong gains6
Modest gains6
Flat weeks0
Modest losses9
Sharp losses5
Recent vol8.3%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -6.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape27/100

Trend, activity pressure, participation, and risk combine to a 27/100 tape read.

 Indicator analysis32/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.15; No reversal markers Factors43/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 5; Small Cap Core rank 66 SVQF76/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 242.0 of 1013 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options60/100

DOCS shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 7.20, expected move of 20.2%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 20.2% Sentiment49/100

Weighted news tone is neutral across 55 relevant articles.

Edgestream Partners L.P. Purchases 132,733 Shares of Doximity, Inc. $DOCS Insiders10 / 10

10 acquisitions and 10 disposals in the latest 180-day insider tape.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202620.91 USD2.4%25.20 USD39.87 USD0.73-52.8018.6MOff
24 Jul 202620.42 USD-5.1%25.95 USD39.95 USD0.75-54.3714.1MOff
17 Jul 202621.52 USD-1.1%26.72 USD40.05 USD0.83-53.2112.0MOff
10 Jul 202621.77 USD-0.4%27.46 USD40.13 USD0.71-54.3613.0MOff
3 Jul 202621.86 USD4.7%28.20 USD40.22 USD0.61-54.5016.3MOff
26 Jun 202620.88 USD2.1%29.00 USD40.29 USD0.53-56.5122.6MOff
19 Jun 202620.46 USD2.1%30.02 USD40.37 USD0.47-59.2512.9MOff
12 Jun 202620.04 USD-2.7%31.02 USD40.45 USD0.51-60.5116.2MOff
5 Jun 202620.59 USD-3.8%32.00 USD40.53 USD0.61-59.9616.0MOff
29 May 202621.40 USD7.3%33.13 USD40.60 USD0.63-60.2115.5MOff
22 May 202619.94 USD5.1%34.61 USD40.67 USD0.59-63.0025.0MOff
15 May 202618.97 USD-27.0%36.18 USD40.74 USD0.47-65.0758.0MOff
8 May 202625.98 USD4.0%37.80 USD40.82 USD0.25-52.8513.1MOff
1 May 202624.98 USD4.0%39.12 USD40.87 USD-0.12-54.4212.0MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.